Reference
McBain H, et al. A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis: a cost-effectiveness analysis. Rheumatology : 30 Jul 2020. Available from: URL: http://doi.org/10.1093/rheumatology/keaa309
Rights and permissions
About this article
Cite this article
Patient-initiated DMARD self-monitoring service not cost effective. PharmacoEcon Outcomes News 860, 26 (2020). https://doi.org/10.1007/s40274-020-7072-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7072-2